TUESDAY, July 25, 2023 (HealthDay News) – Heart disease is a high risk for people with HIV, but a new study finds that taking statins significantly reduces the risk of serious heart incidents. People with HIV who took a daily statin pill lowered their risk of stroke, heart attack orContinue Reading
MONDAY, July 24, 2023 (HealthDay News) — Breakthrough new drugs that clear amyloid beta plaques from the brain are shaking up the field of Alzheimer’s disease research. The fact that patients’ mental deterioration slows when they’re on anti-amyloid drugs is solid proof that abnormal amyloid proteins are one of theContinue Reading
MONDAY, July 24, 2023 (HealthDay News) — Tornado damage to a Pfizer drug-making plant in North Carolina is unlikely to trigger drug shortages across the country, the U.S. Food and Drug Administration says. “We do not expect there to be any immediate significant impacts on supply, given the products areContinue Reading
MONDAY, July 17, 2023 (HealthDay Now) — Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year. The U.S. Food and DrugContinue Reading
MONDAY, July 17, 2023 (HealthDay News) — Another experimental drug meant to slow the damage of Alzheimer’s appears poised to join a growing arsenal of new treatments for this memory-robbing disease. In research published online Monday in the Journal of the American Medical Association and presented simultaneously at the Alzheimer’sContinue Reading
THURSDAY, July 13, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved the nation’s first over-the-counter birth control pill, a move that will likely pave the way for far greater access to contraception for Americans. Women will be able to buy the progestin-only oral contraceptive atContinue Reading
WEDNESDAY, July 12, 2023 (HealthDay News) — Teens who use stimulant medication like Ritalin to treat attention-deficit/hyperactivity disorder (ADHD) do not have an increased risk of illicit drug use later, a new study finds. This study looked specifically at cocaine and methamphetamine use. High school seniors who used stimulant therapyContinue Reading
TUESDAY, July 11, 2023 (HealthDay News) — The European Medicines Agency is investigating concerns that popular weight-loss drugs like Ozempic and Saxenda may be linked to suicidal thoughts and thoughts of self-harm. Three case reports from Iceland spurred the agency’s safety committee to conduct a medication review, CNN reported Monday.Continue Reading
TUESDAY, July 11, 2023 (HealthDay News) — Using marijuana regularly might increase the risk for complications during and after surgery, and doctors should address this when planning operations, a new study suggests. People with a cannabis use disorder are 20% more likely to have serious complications, such as stroke orContinue Reading
TUESDAY, July 11, 2023 (HealthDay News) — A fentanyl dealer has been found guilty of second-degree murder in what authorities believe is the first-ever murder conviction for dealing the dangerous drug. The conviction happened in Placer County, Calif., in a case involving the fatal overdose last summer of a 15-year-oldContinue Reading
MONDAY, July 10, 2023 (HealthDay News) — The drugs Wegovy and Ozempic are all the rage for weight loss these days, and now a new study shows these injections may be game-changers for obese teenagers, too. This trial, funded by drug maker Novo Nordisk, found that nearly half of allContinue Reading
FRIDAY, July 7, 2023 (HealthDay News) — Infectious disease experts are warning that a shortage of a key antibiotic for treating the sexually transmitted infection syphilis could make it hard to fight the spread of the disease. The United States already has a big problem with syphilis, with cases risingContinue Reading
FRIDAY, July 7, 2023 (HealthDay News) — The use of antipsychotic medication in children is continuing to plummet, likely because of better policies and education, new research shows. The study found a 43% drop in antipsychotic prescriptions for Medicaid-enrolled children in 45 states, a stark contrast from the sharp riseContinue Reading
THURSDAY, July 6, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug.Continue Reading